HCW Biologics Inc.

NASDAQ: HCWB · Real-Time Price · USD
4.14
-0.20 (-4.61%)
At close: Aug 15, 2025, 2:18 PM

HCW Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-30.02M -24.99M -14.9M -12.86M
Depreciation & Amortization
1.18M 1.14M 717.85K 543.6K
Stock-Based Compensation
1.01M 1M 1.12M 360.98K
Other Working Capital
775.08K -5.14M 2.35M -2.8M
Other Non-Cash Items
-418 4.98M 188.46K 28.26K
Deferred Income Tax
n/a n/a n/a -501.48K
Change in Working Capital
13.6M -4.64M 2.49M 1.46M
Operating Cash Flow
-14.23M -22.51M -10.39M -10.98M
Capital Expenditures
-261.62K -6.2M -10.28M -47.26K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -34.97M
Sales Maturities Of Investments
n/a 10M 24.98M n/a
Other Investing Acitivies
n/a n/a 24.98M -34.97M
Investing Cash Flow
-261.62K 3.8M 14.71M -35.02M
Debt Repayment
6.79M -38.27K 6.45M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a -2.82M
Other Financial Acitivies
2.32M n/a -190.55K -6.76M
Financial Cash Flow
15.57M -14.53K 6.27M 49.27M
Net Cash Flow
1.08M -18.73M 10.6M 3.27M
Free Cash Flow
-14.49M -28.72M -20.66M -11.02M